foreign corrupt practices act and the health care...
TRANSCRIPT
1 Use this layout as Title Page for
presentation with longer title
names
©2011 Foley & Lardner LLP • Attorney Advertising • Prior results do not guarantee a similar outcome • Models used are not clients but may be representative of clients • 321 N. Clark Street, Suite 2800, Chicago, IL 60654 • 312.832.4500
Foreign Corrupt Practices Act and the Health Care Industry
ACC Health Law Committee April 5, 2011
©2011 Foley & Lardner LLP
FCPA ENFORCEMENT ACTIVITY
FCPA Prosecutions 2003-2010
0 5
10 15 20 25 30 35 40 45 50
2003 2004 2005 2006 2007 2008 2009 2010
DOJ SEC
©2011 Foley & Lardner LLP
TOP 10 FCPA-RELATED MONETARY SETTLEMENTS
(figures in millions)
$137.4 $81.9
$58.3 $56.2
$800 $579
$400 $365
$338 $185
Siemens (2008) KBR/Halliburton (2009)
BAE Systems (2010) ENI/Snamprogetti (2010)
Technip (2010) Daimler (2010)
Alcatel-Lucent (2010) Panalpina (2010)
ABB (2010) Pride International (2010)
©2011 Foley & Lardner LLP
RECORD FINES AND PENALTIES
Individual defendant sentences: – Charles Paul Edward Jumet – 87 months incarceration – Nam Qouc Nguyen – 16 months incarceration – Jason Edward Steph – 15 months incarceration – An Quoc Nguyen – 9 months incarceration – Gerald Green – 6 months incarceration – Patricia Green – 6 months incarceration – Leo Winston Smith – 6 months incarceration – Frederick Bourke – 366 days incarceration – Jim Bob Brown – 366 days incarceration – Bobby J. Elkin – 3 years probation – Joseph Lucas – 2 years probation – Kim Anh Nguyen – 2 years probation
©2011 Foley & Lardner LLP
FCPA Enforcement in the Health Care Industry Representative Enforcement Actions in the Health Care
Industry: – AGA Medical (kickbacks to Chinese physicians) – DPC (improper commission payments to Chinese physicians
and lab techs) – HealthSouth (add-on FCPA charges for improper payments to
Saudi officials to secure hospital management contract) – Immucor (payments to director of public hospital in Italy) – Micrus (inaccurately recorded payments to physicians in
France, Turkey, Spain and Germany) – Schering-Plough (charitable donation in Poland) – Siemens (included charges for payments to officials in China
and Vietnam) – Syncor (improper commission payments to physicians in
Taiwan and Mexico; improper hospitality provided to physicians in Western Europe)
©2011 Foley & Lardner LLP
FCPA Enforcement in the Health Care Industry – Public Disclosure of Pending Investigations
Astra Zeneca Bausch & Lomb (providing
free product through Spanish sub)
Biomet Bio-Rad Laboratories Eli Lilly Medtronic Orthofix (Mexico)
Pfizer Philips (sale of medical
equipment in Poland) SciClone Smith & Nephew Stryker Talecris Wright Medical Group Zimmer
©2011 Foley & Lardner LLP
KEY DEVELOPMENTS IN 2010
The Dodd-Frank Act includes a program providing bounties for FCPA whistleblowers
The UK passed the UK Bribery Act of 2010, which criminalizes: – Commercial bribery – A company’s failure to prevent bribery
The SEC charged a company that is not a U.S. issuer with violating the FCPA (Panalpina case)
Continued focus on the prosecution of individuals More aggressive, traditional law enforcement tactics
employed Preview of 2011:
– Individual jury trials – Challenges to “foreign official” interpretation
©2011 Foley & Lardner LLP
THE BASICS:
The FCPA’s Prohibitions and Essential Elements
©2011 Foley & Lardner LLP
TWO MAIN COMPONENTS:
Anti-Bribery Provisions
Books and
Records and Internal Control Provisions
©2011 Foley & Lardner LLP
ANTI-BRIBERY PROVISIONS
Applies to: – Domestic concerns (“private” companies, LLC’s, etc., and
U.S. citizens); – Issuers (basically, “public” companies); and – Any person who, while in the U.S., commits an improper act
Covers payments made by third parties with “knowledge” that the payment would be used to fund FCPA-illegal activity
Extra-territorial jurisdiction
©2011 Foley & Lardner LLP
WHAT IS PROHIBITED?
The anti-bribery provisions prohibit: – Paying or offering to pay “anything of value” – Directly or indirectly – To a “foreign official,” or to any other person “while
knowing” that all or part of the thing of value will be paid or offered to a foreign official
– Corruptly – For the purpose of influencing the official in some
official act or to secure any improper advantage – In order to “obtain or retain business”
©2011 Foley & Lardner LLP
“ANYTHING OF VALUE”
Examples: Cash or a cash equivalent Travel expenses and/or
payment of personal expenses
Services Golf outings or other
entertainment unrelated to customary entertainment connected with a particular deal or contract
Charitable donations Loans
©2011 Foley & Lardner LLP
“FOREIGN OFFICIAL”
Any officer or employee of a foreign government or any department, agency, or instrumentality thereof – Includes employees of state owned or controlled
enterprises (“SOEs”) – No distinction made as to rank or title (CEO as well
as engineer or procurement manager, or even the janitor)
©2011 Foley & Lardner LLP
“OBTAIN OR RETAIN BUSINESS”
FCPA only covers payments made for a business purpose – Includes payments related to the renewal of
contracts, the execution or performance of contracts, or the retention of existing business
However: – DOJ and SEC interpret this element very broadly
Even unsuccessful bribery attempts are grounds for prosecution – Monsanto (2005)
©2011 Foley & Lardner LLP
EXCEPTIONS & AFFIRMATIVE DEFENSES
Limited nature of exceptions – A payment does not violate the FCPA if its purpose is
to expedite or secure the performance of a routine governmental action ordinarily and commonly performed by a foreign official
– Emerging “best practice” – prohibition of facilitating payments except where the health and safety of an employee is involved
©2011 Foley & Lardner LLP
EXCEPTIONS & AFFIRMATIVE DEFENSES (cont.)
Affirmative Defenses (i.e., company bears the burden of establishing the elements) – Payments lawful under the written laws and
regulations of the foreign country – Custom is not the same as written laws and
regulations Reasonable and bona fide expenditures directly
related to the promotion or demonstration of product or services or the execution or performance of a contract
©2011 Foley & Lardner LLP
BOOKS & RECORDS AND INTERNAL CONTROL PROVISIONS
Apply to: – “Issuers” only, but SEC takes the view that they also apply
to any affiliate whose financial results appear in the consolidated financial statements of the issuer
Require: – Books, records, and accounts must be kept in reasonable
detail to accurately and fairly reflect transactions and disposition of assets; and
– Internal accounting controls sufficient to provide reasonable assurances that, among other things, transactions are executed in accordance with management’s authorization and are accurately recorded
©2011 Foley & Lardner LLP
BOOKS & RECORDS AND INTERNAL CONTROL PROVISIONS (cont.)
Regulators do not need to prove an underlying antibribery violation
Failure to describe what actually occurred is a violation
Recent enforcement actions involved improper payments disguised as: – “commissions” – “consulting fees” – “advertising and promotions” – “transportation expenses” – “cost of goods sold” – “processing fees” – “miscellaneous expenses”
©2011 Foley & Lardner LLP
COMMON ISSUES: AGENTS & DISTRIBUTORS
U.S. companies are not insulated from FCPA risks by doing business in foreign countries through third parties such as agents or distributors
Rather, the FCPA also prohibits payments to third-parties if the company knows or has reason to know that all or part of the payment will be given to a foreign official
Regulators do not need to prove that the third-party acted on the company’s direct orders or even that a company actually knew the intermediary engaged in prohibited conduct
©2011 Foley & Lardner LLP
THIRD-PARTY PAYMENT PROVISIONS
Willful Blindness = Knowledge
©2011 Foley & Lardner LLP
RED FLAGS
In the event a third-party ends up making an improper payment, a due diligence file that shows a thorough investigation and no red flags will be the company’s best defense against an enforcement action by the U.S. government, or, at the very least, the best argument for mitigating any fine or penalty
©2011 Foley & Lardner LLP
COMMON ISSUES: THE PERILS OF HOSTING CUSTOMER VISITS
Travel expenses can be paid, provided done in good faith and not with corrupt intent or expectation of a favor
Travel and accommodations must be reasonable and directly related to a legitimate business purpose
Issuer’s books and record must accurately reflect value and purpose of travel
Best practices – Any side trips should be modest and incidental – Expenses should be paid only for attendee (i.e., not spouse or
relatives) – No per diem should be given – Written notification of trip should be given to government/
organization that employs the recipient – Delegation members should be picked by foreign government,
not company
©2011 Foley & Lardner LLP
COMMON ISSUES: MEALS & ENTERTAINMENT
Companies may provide meals and entertainment, if in good faith, without corrupt intent, and with no expectation of a favor
Must be directly related to legitimate business purpose Must be reasonable in value If an issuer, books and records must accurately reflect the
value and nature of all meals and entertainment Best practices:
– Should be in accordance with generally accepted business standards
– Company personnel should be in attendance – Should be properly documented – Whenever entertaining government officials, should have
procedures to have cleared by compliance officer/GC
©2011 Foley & Lardner LLP
COMMON ISSUES: CHARITABLE CONTRIBUTIONS
Companies may provide gifts or contributions to charities, if in good faith, without corrupt intent, and with no expectation of a favor
Even though payment is not made directly to a government official, if the contribution is urged by official as quid pro quo for business or approval, could be a violation
Case in point: Schering-Plough – $76,000 paid over four years to charity operated by government official
Best practices: – Due diligence before charitable contributions – Special care where government official has position with charity – Public disclosure of contribution – Following donation, confirmation that donation used for intended
purpose
©2011 Foley & Lardner LLP
FCPA ISSUES & THE REGULATORS
Internal investigation is a no-brainer The self-disclosure issue Dealing with outside auditors Deferred prosecution and non-prosecution agreements
– Promise of continuing cooperation with investigations and continuing reporting
– Agreement to commit no additional violations for fixed period of time
– Usually provide for monetary penalties – Usually require upgraded compliance and risk-management
programs and appointment of compliance monitor Appointment of compliance monitors
– More nuanced view; not default provision in settlements
©2011 Foley & Lardner LLP
FCPA COMPLIANCE
What the regulators expect – Requirements of an effective compliance program
Risk-based compliance efforts key
©2011 Foley & Lardner LLP
ASSESS FCPA RISK
FCPA compliance risk is a combination of – Who (public vs. private customers) – What (large public projects vs. producing widgets) – Where (the country’s corruption reputation) – How (use of third parties)
Focus on all variables – Recent FCPA enforcement actions instruct that while
compliance efforts should focus on high-risk situations, business leaders must be alert to the risks present in all countries in all situations
©2011 Foley & Lardner LLP
CORRUPTION PERCEPTION INDEX (2009)